Key facts
- This page summarizes Ian Malcolm McRobbie's Form 4 filing for INNOSPEC INC. (IOSP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 25 Feb 2026, 17:36.
Ian Malcolm McRobbie - 23 Feb 2026 Form 4 Insider Report for INNOSPEC INC. (IOSP)
- Reporting relationship
- Senior VP R&T
- Issuer ticker
- IOSP
- Reported as of
- 23 Feb 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Feb 2026, 17:36:07 UTC
- Prior SEC filing
- 27 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- Ian Malcolm McRobbie
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ian Malcolm McRobbie filed Form 4 for INNOSPEC INC. (IOSP) on 25 Feb 2026.
Change
- Previous filing in this sequence was filed on 27 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001233480
Primary reporting owner
MCROBBIE IAN MALCOLM
- Relationship
- Senior VP R&T
- Address
- 8310 SOUTH VALLEY HIGHWAY, SUITE 350, ENGLEWOOD
- Signature
- Ian Malcolm McRobbie
- Signature date
- 25 Feb 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IOSP
transaction
Derivative
Phantom Stock
Award
- Transaction value
- $0
- Shares
- +2,228
- Change %
- Price
- $0.000000
- Shares after
- 2,228
- Date
- 23 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,228
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Each share of phantom stock is the economic equivalent of one share of Innospec common stock. The award is scheduled to automatically settle in cash on the Expiration Date based on the closing price of Innospec common stock on that date.